{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:54:36Z","timestamp":1793904876418,"version":"4.8.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,13]]},"DOI":"10.1097\/qad.0b013e32835cb747","type":"journal-article","created":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T09:18:50Z","timestamp":1354094330000},"page":"769-779","source":"Crossref","is-referenced-by-count":77,"title":["Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment"],"prefix":"10.1097","volume":"27","author":[{"given":"Giuseppe","family":"Lapadula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cozzi-Lepri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Antinori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Chiodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Nicastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Parruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella d\u2019Arminio","family":"Monforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R2-10-20210130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00042560-200106010-00011","article-title":"Prognostic factors of combined viral load and CD4 cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998.","volume":"27","author":"Marimoutou","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-10-20210130","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1086\/342695","article-title":"Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4 cell counts after successful virologic suppression.","volume":"35","author":"Dronda","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R4-10-20210130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/01.qai.0000182847.38098.d1","article-title":"Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy.","volume":"40","author":"Moore","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-10-20210130","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/QAI.0b013e31816856c5","article-title":"Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy.","volume":"47","author":"Tan","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-10-20210130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QAI.0b013e3181ec28ff","article-title":"A CD4 cell count 200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.","volume":"55","author":"Loutfy","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-10-20210130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/QAD.0b013e32834f32f8","article-title":"Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort.","volume":"26","author":"van Lelyveld","year":"2012","journal-title":"AIDS"},{"key":"R8-10-20210130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7326\/0003-4819-133-6-200009190-00007","article-title":"Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.","volume":"133","author":"Grabar","year":"2000","journal-title":"Ann Intern Med"},{"key":"R10-10-20210130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/157016208783885038","article-title":"Patients characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy.","volume":"6","author":"Gutierrez","year":"2008","journal-title":"Curr HIV Res"},{"key":"R11-10-20210130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/1471-2334-10-318","article-title":"Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study.","volume":"10","author":"Engsig","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R12-10-20210130","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/603557","article-title":"Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.","volume":"49","author":"DArminio","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R13-10-20210130","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"R14-10-20210130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"R15-10-20210130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-0320(19991015)38:5<231::AID-CYTO5>3.0.CO;2-Y","article-title":"Enumeration of CD4() T-cells in the peripheral blood of HIV-infected patients: an interlaboratory study of the FACSCount system.","volume":"38","author":"Lopez","year":"1999","journal-title":"Cytometry"},{"key":"R17-10-20210130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/cyto.10094","article-title":"Quality control of CD4 T-lymphocyte enumeration: results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for Immune Monitoring (1993-2001).","volume":"50","author":"Whitby","year":"2002","journal-title":"Cytometry"},{"key":"R18-10-20210130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.qai.0000247229.68246.c5","article-title":"Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4 counts greater than 200cellsmm3.","volume":"44","author":"Lau","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-10-20210130","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/QAI.0b013e3181e9be6b","article-title":"Serious fatal and nonfatal non-AIDS-defining illnesses in Europe.","volume":"55","author":"Mocroft","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R20-10-20210130","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/QAD.0b013e3283365356","article-title":"Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.","volume":"24","author":"Neuhaus","year":"2010","journal-title":"AIDS"},{"key":"R21-10-20210130","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/651688","article-title":"Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study.","volume":"50","author":"Prosperi","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R22-10-20210130","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4 T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.","volume":"187","author":"Hunt","year":"2003","journal-title":"J Infect Dis"},{"key":"R23-10-20210130","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/01.aids.0000242819.72839.db","article-title":"Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.","volume":"20","author":"Marchetti","year":"2006","journal-title":"AIDS"},{"key":"R24-10-20210130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/QAD.0b013e328337b957","article-title":"CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART.","volume":"24","author":"Massanella","year":"2010","journal-title":"AIDS"},{"key":"R25-10-20210130","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/QAD.0b013e32834c4ac1","article-title":"Impact of CD8 T-cell activation on CD4 T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.","volume":"25","author":"Hunt","year":"2011","journal-title":"AIDS"},{"key":"R26-10-20210130","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis.","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"R27-10-20210130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/infdis\/jiq071","article-title":"T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.","volume":"203","author":"Kaplan","year":"2011","journal-title":"J Infect Dis"},{"key":"R28-10-20210130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0065-230X(02)84008-8","article-title":"Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer.","volume":"84","author":"Dalgleish","year":"2002","journal-title":"Adv Cancer Res"},{"key":"R29-10-20210130","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/QAD.0b013e3283112d29","article-title":"Microbial translocation is associated with sustained failure in CD4 T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.","volume":"22","author":"Marchetti","year":"2008","journal-title":"AIDS"},{"key":"R30-10-20210130","doi-asserted-by":"crossref","first-page":"e18580","DOI":"10.1371\/journal.pone.0018580","article-title":"Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy.","volume":"6","author":"Merlini","year":"2011","journal-title":"PLoS One"},{"key":"R31-10-20210130","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/QAD.0b013e3283471d10","article-title":"Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4 cell count.","volume":"25","author":"Marchetti","year":"2011","journal-title":"AIDS"},{"key":"R32-10-20210130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging.","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"key":"R33-10-20210130","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.exger.2006.12.003","article-title":"Accelerated immune senescence and HIV-1 infection.","volume":"42","author":"Appay","year":"2007","journal-title":"Exp Gerontol"},{"key":"R34-10-20210130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/QAI.0b013e3181add695","article-title":"CD8 hyperactivation and senescence correlate with early carotid intima-media thickness in HIV patients with no cardiovascular disease.","volume":"51","author":"Tincati","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R35-10-20210130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/QAI.0b013e31817bebb3","article-title":"Poor initial CD4 recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.","volume":"48","author":"Baker","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R36-10-20210130","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1086\/429670","article-title":"Mechanisms involved in the low-level regeneration of CD4 cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.","volume":"191","author":"Benveniste","year":"2005","journal-title":"J Infect Dis"},{"key":"R37-10-20210130","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1097\/01.aids.0000247588.69438.fd","article-title":"T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART.","volume":"20","author":"Marziali","year":"2006","journal-title":"AIDS"},{"key":"R38-10-20210130","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/00002030-200107060-00018","article-title":"Discordant CD4 T lymphocyte responses to antiretroviral therapy for HIV infection are associated with ex-vivo rates of apoptosis.","volume":"15","author":"Pitrak","year":"2001","journal-title":"AIDS"},{"key":"R39-10-20210130","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/QAD.0b013e328339cf40","article-title":"Skewed T-cell maturation and function in HIV-infected patients failing CD4 recovery upon long-term virologically suppressive HAART.","volume":"24","author":"Marchetti","year":"2010","journal-title":"AIDS"},{"key":"R40-10-20210130","doi-asserted-by":"crossref","first-page":"e7658","DOI":"10.1371\/journal.pone.0007658","article-title":"HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.","volume":"4","author":"Mavigner","year":"2009","journal-title":"PLoS One"},{"key":"R41-10-20210130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/QAI.0b013e318134257a","article-title":"HIV-infected adults with a CD4 cell count greater than 500cellsmm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.","volume":"46","author":"Lewden","year":"2007","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201303130-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T12:59:02Z","timestamp":1643720342000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201303130-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,13]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32835cb747","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,13]]}}}